Obsessive-compulsive Disorder With Acute Onset

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Obsessive-compulsive Disorder With Acute Onset trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT04806620

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

The unhide® Project is a non-interventional, longitudinal research study designed to establish a secure data repository of demographic, health, and lifestyle in…

United States10,000 participantsStarted 2023-07-05

All recent trials (4 shown)

CompletedNot Applicable

NCT02190292

PANS - A Detailed Study of the Patients, Their Symptoms, Biomarkers and Treatment Offered in a Scandinavian Cohort

Background: Obsessive-compulsive disorder (OCD) is considered one of the most debilitating of the psychiatric illnesses, yet much remains unclear regarding caus…

Sweden185 participantsStarted 2014-06

UnknownPhase 4

NCT03348618

A Study to Evaluate the Benefit of Octagam 5%® in Subjects With Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)

This study will evaluate the use of intravenous immunoglobulins (IVIG) at a dose of 1g/Kg/body weight given every three weeks for 6 infusions in pediatric subje…

United States21 participantsStarted 2017-11-24

Treatment: IVIG

Obsessive-compulsive Disorder With Acute Onset

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

All recent trials (4 shown)

PANS - A Detailed Study of the Patients, Their Symptoms, Biomarkers and Treatment Offered in a Scandinavian Cohort

A Study to Evaluate the Benefit of Octagam 5%® in Subjects With Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

All recent trials (4 shown)

PANS - A Detailed Study of the Patients, Their Symptoms, Biomarkers and Treatment Offered in a Scandinavian Cohort

A Study to Evaluate the Benefit of Octagam 5%® in Subjects With Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)

Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS)